Transforming C. difficile Care
Overview
The first portion of this recording dives into the treatment and prevention strategies for both initial and recurrent C. difficile infections.
Learning objectives
- Initial Discussion: Gain insights into the most effective antimicrobial regimens for both initial and recurrent C. difficile infections.
- Initial Discussion: Explore the supplementary therapeutics employed to prevent the recurrence of C. difficile infections.
- Initial Discussion: Examine FDA-approved live biotherapeutic products and the supporting safety and efficacy data.
- REBYOTA Presentation: Comprehend the microbial composition, potency, and standardized manufacturing process behind REBYOTA.
- REBYOTA Presentation: Evaluate the efficacy and safety data associated with REBYOTA.
- REBYOTA Presentation:Engage in a discussion regarding the utilization of REBYOTA in clinical practice and its impact on the patient experience.
Key dates
- Released date:
- Nov 02, 2023
- Expiration date:
- Nov 01, 2025
Pricing
Agenda
All times are Eastern.
Session Heading 1: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Session Heading 2: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Course contents
Video
43 mins
Evaluation
Course Faculty
Product Theater Presenter
Candace Cotto, RN
Medical Research Center Connecticut, LLC
Speaker
Paul Feuerstadt MD, FACG, AGAF
Assistant Clinical Professor of Medicine
Division of Digestive Disease Yale-New Haven Hospital PACT Gastroenterology Center Milford, CT
Sahil Khanna, MBBS, MS
Professor of Medicine
Division of Gastroenterology and Hepatology Mayo Clinic Rochester, MN
Jessica Gold, RD, CDN, CNSC
Clinical Nutritionist
Center for Advanced Digestive Care New York Presbyterian/Weill Cornell Medical Center
Jessica Allegretti, MD, MPH
Medical Director of the Crohn’s and Colitis Center Brigham and Women’s Hospital Boston, MA